GILD

NOT_MartinShkreli

GILD and LLY just ignoring the market

callsonreddit

I think during tariff era $ rotated to science and insurance stocks like BRO, GILD, AMGN They are flat in pre-market which means it's kinda true

sidslidkid

Gilead Sciences (GILD) has been such an underrated stock.

sidslidkid

Gilead (GILD) has quietly been on quite a run lately

NOT_MartinShkreli

GMAB is best down and their oncology products + pipeline is legit GILD owns the HIV market for the most part and acquired an oncology company a couple years ago. Their sales will be booming for a while. Just broke out and probably going to new highs (no target just buy and hold forever) Halozyme makes oncology drugs formulated for subcutaneous injection … nobody wants to sit in an infusion chair … only going up. Buy and hold Takeda is the sleeping giant of Japan and is just a great company. Beat down and has dividend. Buy and hold. Editas is gene editing company that’s beat way down. It’s more speculative but I’ll take the bet. Merck I just think sucks lol. Fuck Merck. They just totally screwed scynexis who has a very promising antifungal that is going to invade their space.

NOT_MartinShkreli

I’d go long on GMAB, GILD, HALO, EDIT, or TAK before MRK

sidslidkid

GILD is up nearly 5% on the day

sidslidkid

GILD is having a solid day.

Bastosluis244

It's still at a good price to purchase some shares. Now that BARDA gave them upwards of 300M dollars to develop their product, and today, the FDA gave them a new "Breakthrough Designation", coupled with an expanded 100M subjects to test the medicine, coming from the 50M they had previously (just a few weeks ago)... Plus, the push from the FDA to approve this medicine ASAP, before the seasonal flu kicks in... Yeah... Everything points to an increase in price of each share even higher than the original price around the company's IPO, 10 years ago, of around 350$ a share... And regarding a potential buyout (which is very possible, bearing in mind what usually happens with these smaller companies, when they develop something as groundbreaking as this)... Well... If we consider the IPO's evaluation as a starting point, around 350$... And bearing in mind how lucrative this business is... We might see each share, after an FDA approval and mass production/distribution of this drug around the US - and if Cidara doesn't decide to dilute their shares until there - of around...well...this is just speculative, obviously, but around 600/700 dollars each share wouldn't be that farfetched... This would make Cidara worth, let's say... Between 10 and 15 Billion dollars... And considering that, for example, Gilead Sciences, has an evaluation of around 147 Billion dollars... A potential buyout from a company such as this one, would (in theory) happen for much more than Cidara's evaluation at the time... Let's say Cidara's value is at 15B flat. If a company like Gilead decided to buy Cidara, while keeping Cidara's infrastructure intact... Well...just like any business, Cidara could, theoretically, ask for 25/30/40 Billion dollars for said buyout - this is totally normal, since no company would want to sell themselves for the price they're evaluated at that time and, instead, would extrapolate their value based on their potential and future upside. If something like that were to happen, then you could see your investment double just because of said acquisition, and your CDTX would be converted into (in this hypothetical reality) GILD stocks - with the ×2 of the acquisition already in mind. So yeah.. I first came across this project around 3 months ago, and decided to purchase several of their shares at around $50, after doing some exhaustive investigation regarding their project. And since, at that time, I saw so many green flags regarding their project and their potential growth in the medium term, I've decided to purchase a good amount of shares at $50 each... And...yeah, best decision of my life, I'm sure of that... So...even at $110, based on every single narrative going around at the moment... Investing in their shares is a freaking no brainier!!!

Recent_Register_2952

its for sure a big time yield trap ET is similar and slightly better choice if you are just chasing yield. MY retard opinion that is not financial advice is to maybe look into MO or BTI, perhaps GILD if you want some yield + upside but generally speaking high yield divs not gonna show much growth. Regardless VZ is shit lol

sidslidkid

GILD is having a good day. Not sure why, but green is good.

wolfmansbrotherw07

https://preview.redd.it/x0evtion9ysf1.png?width=1422&format=png&auto=webp&s=b223b4f2be154e3844afb2059aade9323d401f0f GILD interesting option activity. $500K OTM BTO order to put Volume at 5,026 vs OI of 2. Trade doesn't appear to be tied to other legs looking at chains

moorhound

#Buy all the fuckin' US pharma stocks tomorrow. LLY, JNJ, ABBV, MRK, PFE,BMY, AMGN, GILD, fucking all of em

OilBull

I bought 100 shares of GILD and ABBV to write covered calls at the top

OilBull

I bought 100 shares of GILD and ABBV to write covered calls at the top

Ready2gambleboomer

*They killed my GILD poots dead.* *R.I.P. my monies. Fuck.*

Ready2gambleboomer

*Every medical stock on Earth is going down. I buy poots on GILD and she fucks me in my pooter. damn it man smh.*

sidslidkid

I need GILD to have a good day today

Gloomy_MTTime420

Here's the ToS message when you attempt to buy $OST. https://preview.redd.it/e49f1tddoagf1.png?width=361&format=png&auto=webp&s=7bb529646888d915377942989d5873787502d44d 3:01 PM EDT, July 30, 2025 (Benzinga Newswire) If you recently invested in **Pheton Holdings Ltd** (NASDAQ:[PTHL](https://www.benzinga.com/stock/PTHL#NASDAQ)), The Bear Cave warns that you may have fallen victim to a [pump-and-dump scheme](https://www.benzinga.com/topic/short-sellers). **What To Know:** The Bear Cave released a [report](https://thebearcave.substack.com/p/problems-at-pheton-holdings-pthl) on Chinese health care company Pheton Holdings on Tuesday, which sparked a massive sell-off in shares. The weakness has continued on Wednesday following the short seller’s stark warning. The Bear Cave warned Tuesday morning that overseas groups appeared to be manipulating the stock price of Pheton and investors were “at risk of a near-term, severe stock collapse.” The collapse has played out over the past two trading sessions, with shares tumbling more than 90% on Tuesday and being halted multiple times amid aggressive selling. The short-focused research firm alleged that “overseas scammers” were running up the price of Pheton based on false rumors that **Gilead Sciences** (NASDAQ:[GILD](https://www.benzinga.com/stock/GILD#NASDAQ)) was preparing to acquire or partner with the company.

iggy555

GILD

LocalFuel8139

is GILD worth it? Q2 seems to be strong

dvdmovie1

Anytime a pharma "growth story" starts to slow and there's nothing compelling in the pipeline for the immediate future, you see a re-rating to a degree that most investors aren't used to. You saw it with GILD in the mid 2010's after the Hep-C drugs started to slow - went from a hot stock to cratering and then taking 10 years to get back to prior highs. Moderna has round tripped all the way back to early 2020 levels. Novo's patent on semaglutide starts to expire in 2026. Giant generic pharma co Sandoz has already talked about the GLP-1 opportunity in generics. NVO's Cagrisema didn't get the reception hoped and given the nature of it it's more expensive to produce. So foreign markets will start to have generic competition starting next year and unless there's a v2.0 drug, they're going to face more competition beyond just LLY. There's been tons of posts about this company that act like nothing's wrong and yet they fired the CEO the other week. People keep saying tariffs and that's an issue but it's not the key issue here. This is what it looks like when a pharma/biotech growth story re-rates, time and time again. NVO got overdone to the downside in the 50's/60's, but it's going to take some considerable good news for a sustained move higher. https://www.fiercepharma.com/pharma/eli-lilly-overtaking-novo-nordisk-diabetesobesity-market-analysts ("Eli Lilly is overtaking Novo Nordisk in the diabetes, obesity market: BMO analysts") https://www.pharmavoice.com/news/eli-lilly-novo-nordisk-compound-glp1-earnings/747046/ ("Lilly revealed in a first-quarter earnings report last week that it now has a 53% share of the GLP-1 market, overtaking Novo for the first time") https://qz.com/novo-nordisk-eli-lilly-ozempic-zepbound-weight-loss-1851782626 ('How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race") https://www.reuters.com/business/healthcare-pharmaceuticals/view-wegovy-maker-novo-nordisk-ousts-ceo-competition-obesity-drug-market-heats-2025-05-16/ ("Novo Nordisk CEO's surprise exit after setbacks in weight-loss market: Reaction") https://www.theguardian.com/business/2025/may/07/wegovy-maker-novo-nordisk-cuts-profit-forecast (Wegovy maker Novo Nordisk cuts profit forecast as US prescriptions tail off: Slowdown will deepen concerns Denmark’s biggest company is losing market share to US rival Eli Lilly") etc etc etc. There have been posts for a few months now with people acting like the decline is 100% unjustified which is perplexing. It's a decent value in the low 60's, but people who buy it and expect it to moon tomorrow and completely rebound/re-emerge as the growth story it was a year ago are going to be disappointed.

rando9999912

One of my first personal stock picks was GILD because they did cure Hep C, the stock proceeded to do nothing but cuck me for 5+ years after

dvdmovie1

There is a history in healthcare/biotech where the moment that people think growth is slowing/going to slow in the near-term, people flee the stock in a manner that many investors aren't used to. There's plenty of examples of it, the biggest one that I often use is GILD, which was the hottest stock for a couple of years off Hep-C in the 2010's. The moment that that started to slow, the stock headed South, they threw billions in buybacks and it kept going South. It didn't get back to the prior high until 10 years later. Moderna stock is all the way back to where it was in March 2020, losing everything and then some from when the vaccine was announced later in 2020. Lilly is leading in obesity and NVO's Cagrisema isn't the 2.0 drug that people were hoping it would be. Plus, it's more expensive to make. Novo didn't dump its CEO because everything was going great and the stock market just doesn't understand how awesome it's doing. It's not "over" for Novo and hopefully their new CEO turns things around a bit but people buying it as if it's still the growth story it was a year ago, no - they lost the lead to Lilly. The stock got overdone in the upper 50's/low 60's, bounced and now needs more positive news to have a sustained bounce.

DDDDoooommmmeeee

GILD looking good

Classic_Revolt

GILD needs to take some boner pills cuz they just can not keep this stock up even with drug approval news.

dvdmovie1

> Comparing NVO to GILD/MRNA isn’t correct. I wasn't comparing and stated as such. I'm simply noting that healthcare investors are very, very unforgiving when there is not a next big thing in the pipeline - *whether obesity or otherwise* and there are plenty of examples of that. "And they don’t exactly need a “what’s next” drug" The stock has lost 51% in the last year. Yesterday: "Novo Nordisk shares fall as obesity pipeline faces investor scrutiny" (https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-shares-fall-obesity-pipeline-faces-investor-scrutiny-2025-06-23/) "I’m long on both NVO and LLY" Good luck to you. Am long LLY.

GWillHunting

I think a lot of your points here don’t have much merit, and I’ll explain why: 1. Comparing NVO to GILD/MRNA isn’t correct. GILD was making a drug for hepatitis C? How many people do you know that have hepatitis C? Now how many people do you know that are obese? For MRNA; of course there was going to be a major decline because you only need one Covid vaccine +/- the occasional booster. 2. NVO has the patent in America, along with LLY until 2028 or 2030 (can’t remember which). The point is, they are still the only two players for at least three years. 3. Early bird gets the worm: NVO and LLY were first to market, they already have the brand recognition. And they don’t exactly need a “what’s next” drug when you have the patent for multiple years. If LLYs drug gives 5% more weight loss but it’s twice as expensive, there will still be plenty of people taking Ozempic. It’s not like there can only be one effective weight loss drug that owns the whole market. It was disappointing to see the HIMS contract fall through but there are still tons and tons of people on Ozempic and that will continue to take it. They pay a healthy dividend, good PE ratio right now, my bet is it is back to $100 by EOY. I’m long on both NVO and LLY. For at least the next 1-2 years while they have the patents.

dvdmovie1

"Do you think it is undervalued at the moment and that market overreacted?" Upper 50's/low 60's was a bit much but people have this view that "everything's great" and it's just not the case imo. Semaglutide starts going off patent in other countries next year and Cagrisema has not been the obesity 2.0 follow-up that was wanted/needed. Lilly has pulled ahead in obesity. I think people don't understand that the healthcare sector - perhaps more than any other sector - puts an enormous focus on "what's next?" If there isn't something compelling, or the next thing is disappointing - people flee in a manner that investors often aren't used to. I mean, GILD was a hot stock for a couple of years because their purchase of Pharmasset lead to their very successful Hep-C drugs. When that started to slow and GILD didn't have a compelling answer to "what's next?" people sold. The company did huge buybacks and the stock kept tanking. It took a decade for the company to reach prior highs. I think NVO in the upper 50's or so was overdone but there are real issues that people are ignoring/downplaying. People on here in 2023 kept going on about buying PFE because it was cheap and had an obesity drug too. The drug failed, they tried an oral formulation and that had poor results too. I think too many people have this view as if there's no moat in drugs and why can't everyone be obesity drug winners. It's just not the case and with NVO being less diversified than LLY it's even more important that they continue to get everything right - and they have not.

Simply-Serendipitous

She bought all these on June 4th, reported them yesterday, and spent somewhere between $1k-$15k for each one NFLX NOW NEE GILD AMAT ADBE SNOW

IAmtheCoffeeMachine

GILD is gonna go crazy on Friday. Their HIV drug is testing almost 100% against infection

InevitableAd2436

Surprised more people aren’t on $GILD with their new HIV drug. Half this sub is probably already using pRep

sidslidkid

GILD was supposed to make me rich.

dvdmovie1

Significantly depends on the kind of addressable audience, how much the stock has run up into approval, how much is it going to take (for a company already going through $) to get to launch, what is broader sentiment in biotech (generally varying degrees of bad for a while, especially given continued higher rates), etc etc etc. There's so many factors, it's not just approval = x%. I've owned a number of biotech names and have done reasonably well (have had 3 buyouts this year alone), but it's a very hard sector to do well in and much harder to do consistently well. There's also so much focus on whether something gets bought out or not; you can have an approval and still have a smaller company mismanage things. Few people are hoping that their biotech is the next Regeneron because very, very few biotechs become the next REGN (or VRTX, or ARGX another example) - the good stuff is mostly picked over by big pharma when they need to refill their pipeline. Also, too many people pile into micro cap biotechs because they told a good story and then it turns out to be less/a lot less than advertised. It's a lot easier (at least IMHO) to buy things that are already on the 50 yard line and you think have a reasonable chance of touchdown or at least a kicking a field goal. That said, if something that a lot of people think might be a buyout candidate even hints that's not happening anytime soon, people flee in a manner that I don't think many investors are used to. With healthcare in general, I think that it's very much "what's next" and if there isn't something compelling on deck then you see selling like NVO, or GILD around 10 years ago going from a very hot stock to something that didn't see the highs of the mid 2010's again until recently. Overall, I have materially less in biotech than what I started the year with.

TestingThrowaway100

Saw unusual options activity on GILD on a Twitter app that puts out those notifications.  I was going to buy the same calls but accidentally bought them with 1 day expiry instead of next week expiry.  Next day GILD announced their Covid Vaccine and my calls went up 8x at open. 

Soossaaaa

Why those specific stocks? I'd think GILD is solid one to hold too

sidslidkid

GILD lookin good

NOT_MartinShkreli

I’m a pharmacist and not very big on Pfizer. Personally I like GMAB, TAK, HALO, GILD and a little AI imaging company called NNOX TAK and GILD at least pay a dividend and have way more promising pipelines than Pfizer

NOT_MartinShkreli

No Pfizer is ass long term. Like TAK is better. HALO is better. GMAB is better. GILD is better. BIIB is beat down and likely also better. Don’t make me keep listing better than Pfizer

Xchai

Time to all in GILD?

nskidder

wow, whats up with GILD. my calls are printing

PureSpecialistROTMG

!banbet GILD +6% 3w

FemaleEcho

Whichever one dips the most PFE, JNJ, MRK, ABBV, BMY, AMGN, GILD, NVS, SNY

surmoiFire

Blowflex stock, ZM, ZOOM (the wrong one that people keep buying 🤭), MRNA, VART, GILD

the_macagameianut

I was bored at work and spent a while searching last week for this. Best I could tell (check Politico’s reporting), there’s a major pharma drug lowering cost announcement pending (aka why MRK LLY GILD been getting extra beat up lately). There’s some wildly unpopular industry favored nation deal congress won’t support but apparently he’s found an executive order work around?

falling_knives

Never thought about doing that haha I don't know, not about to look through 500 stocks. Nasdaq has one as well and it currently has 19. PLTR, GILD, DASH, TMUS, MNST, and TTWO to name a few.

BluesFlute

Wait a few weeks for the turmoil to abate. Recession is likely. Look at companies during this time that are resistant. GILD has one of the best HIV drugs…. Used car companies? KMX, CRVA …. Even a boring utilities etf. XLU.

trainwreck001

The GILD I MEAN GOLD CARD? 

Mongoose-Additional

Anyone in GILD?

EjaculatingAracnids

Call on GILD. That and APPL has kept my account barely green.

BluesFlute

Perhaps it depends on one’s strategy. In 90s I was all about buy and hold and buy the dips, etc. Then dot com taught some hard lessons. Preserving capital is important. Using TA to know the trend, and using simple indicators to know when to buy or sell takes the emotional bias out of the decision. Usually I’m fully invested in index ETF and select equities. Since 1/1 I’ve moved to cash and high yield bond funds. Those dividends make a nice monthly plunk! Glad to be holding on to GILD. What’s this? New highs on a down day? Nice trendline. This works for me. I mention it here for the benefit of all young investors. I have an aversion to the “…. for Dummies” book series. However, the “Technical Analysis for Dummies “ was a quick and informative read.

Soossaaaa

if you type a stock opinion everyone downvotes it's a good sign you're right. my track record: - short RDDT - buy GILD - short NVDA - buy TLT New trade: - buy TSLA

TheTravelingTitan

Same here. I bought quite a few puts on GILD Friday at close. We shall see!

NOT_MartinShkreli

TAK and GILD have only gone up lately. Pharma just not following the market pull back. Pharma has been sideways even with large market gains the last few years. I think people are rotating back into pharma again. My TAK $12.50 and $15 April calls that looked cooked a few months ago a up BIGLY

RandomGuyNamedChris

GILD and MCD making new ATH because you all will have aids and eat burgers during recession

NOT_MartinShkreli

GILD and TAK don’t give a fugg about market pull back. Those 2 have only gone up lately

ReBoomAutardationism

Defense Defense GILD! Defense Defense JAZZ! Defense Defense CPRX! Defense Defense NVO! Defense Defense DVAX!

Character_Tax_7255

GILD hits all-time high

Whole-Oil8184

AAPL NVDA AMZN GOOG WMT PANW V BRK.B GILD IBIT bitcoin etf IAUM gold etf Looking to make my porfolio something like this. Should I go even % across tbe board?

Technically_Tactical

$GILD at 52 week highs and may still be undervalued.

Infinite_Prize287

Solid. I've been trading low IV companies for the past year. It's a great strategy if you get the trend right. These low IV companies really tend to ride the trend after earnings or some macro event related to them, like WMT, VZ, KO, BMY, GILD, SBUX, JNJ.

ImmaHeadOnOutNow

Can confirm. Was horny so shilled out another 60 bucks to return to getting fucked by random strangers for the next 6 months. Calls on GRND and GILD

Soossaaaa

GILD has been on a rise the past year and broke out of a 10 year base. With the bird flu going on and their pivot to immunotherapy I think they can 1.5x over the next year

jdogg692021

Problem with paper trading is u set a stop loss u sell at stop loss. In real life somehow if your stock flash crashes you get stopped out at the bottom. This really sucks so I don't do stop losses. So unfortunately, I can only just buy stocks like brk.b, aapl and amaz and hold to make money. I did buy some Reddit stock that was doing pretty well but lately it's down like 10-15 percent from recent highs. Just gonna hold it and wait. Got in at 136. Worst buy I made in last few years was buying GILD at 80 in 2020 it went down to 60 for quite a while but does pay a 4% dividend so I just held. It's finally up to like 100. And has paid me about 16% in dividends. Entry point is huge get in on dips. IMO I picked a terrible entry point on GILD. Good luck!

JahKusto

Feeling bullish or bearish is not the question to ask. Let’s be honest Penny stocks of this magnitude or magnitude-lack of are high Risk, very volatile, and speculative. That being said, let’s take a look at the facts. It did peak up about 30%-40% to about $0.22 on feb 11th before profits were taken. Do I have my own questions and concerns? Absolutely! 1. Did they just make an unregistered sale of Shares on feb 12th? Yes 2. Are they at risk of being delisted? Yes (But when you’re busy in the lab advancing cancer treatment developments who has time for annual meetings?) ——all jokes aside…But with only 7 employees maybe they need to hire an 8th just to keep the annual meeting. Also there are compliancy issues with the minimum Market Value of Listed Securities requirement (this means According to Nasdaq listing requirements, the minimum "Market Value of Listed Securities" is typically $15 million. Meaning that OCEA must have a total market value of its publicly traded shares worth at least $15 million to be listed on the Nasdaq. Financials are not great but I thought this was a place to talk about Penny Stocks (that haven’t run up 100% + yet) ([https://www.investing.com/news/sec-filings/ocean-biomedical-reports-unregistered-equity-sales-93CH-3866151](https://www.investing.com/news/sec-filings/ocean-biomedical-reports-unregistered-equity-sales-93CH-3866151)) 3) Is this company even real, with reliable leaders? Yes. Let’s just start off by saying Dr Michelle M Berry (yes a real Doctor not just a suite) has been doing this for a while and doing it well. ([https://www.bizjournals.com/triangle/print-edition/2015/05/22/life-sciences-m-michelle-berrey.html](https://www.bizjournals.com/triangle/print-edition/2015/05/22/life-sciences-m-michelle-berrey.html)) She’s super qualified with decades of experience, spearheading companies like Pharmasset VRUS which was acquired by GILD for 11 Billion. CMRX which is now trading @ $4.39 where she worked her way UP from Chief “MEDICAL” officer to CEO ([https://www.oceanbiomedical.com/michelle-berrey](https://www.oceanbiomedical.com/michelle-berrey)) Did they really have breakthroughs in Cancer Treatment options, to suppress tumor growth and progression, specifically Lung Cancer? Yes. ([https://drug-dev.com/ocean-biomedical-announces-breakthrough-findings-in-egfr-mutant-lung-cancer-plans-for-fda-alignment-on-next-stage-development/](https://drug-dev.com/ocean-biomedical-announces-breakthrough-findings-in-egfr-mutant-lung-cancer-plans-for-fda-alignment-on-next-stage-development/)) 4) Do they need to need to make an announcement to regain momentum? Yes. (But in all fairness, do they care about day traders, “Paper-Hands & swing traders? Probably not). 5) Did I take some profits? Yes. 6) Am I buying the dips? Yes 7) Would I yolo into this? No 8) Is this the only Biotech Stock in my portfolio? No 9) Is this the best Biotech Stock in my Portfolio? No A lot depends on their next few press releases. This is an a no-nonsense company with Experienced leadership, they don’t Tweet, even tho I wish they would…..They just get the job done. As far as the RS: According to recent filings, Ocean Biomedical (OCEA) is considering a reverse stock split, with the possibility of implementing it before the end of 2025, although the exact ratio and date have not been officially announced; the decision will likely depend on shareholder approval and the company's efforts to maintain compliance with stock exchange listing requirements. MGO was also doing a RS and was facing delisting but was also haulted last week for shooting past $115 There’s a lot to consider here, so in the words of Mike Colvin “Exciting stuff if it all pans out.” https://preview.redd.it/mg5c6twx0dje1.jpeg?width=1290&format=pjpg&auto=webp&s=68860d6ba308435efdb229b775c5e04e075ae1ab

igotshrimps

Lowkey healthcare earnings has been lit, GILD calls keeping my portfolio up today. Probably going into MRNA on Thursday before close...

Captain_Lameson

GILD was the play

Disastrous-Muffin743

GILD up 8% prob because someone mistakenly tought it was GOLD

InquisitorCOC

$GILD in 2015 Thought it was value, but it was actually a value trap

fuckthewoodwork

GILD massive earnings beat and good forecast, fuck the put/call ratio 

Recent_Register_2952

At lest I have some GILD 

fuckthewoodwork

GILD HUGE BEAT! FUCK YOUR PUT RATIO 

yushey__

GILD needs to die

ImHungryAsFuck

Ready to see these $GILD Puts printtttttt

ImHungryAsFuck

$GILD Puts

ImHungryAsFuck

$GILD PUTS for earnings

yushey__

GILD EARNINGS. 📉📉📉📉📉 last chance for 10 bagger

yushey__

Last chance to buy GILD puts. (This is financial advice)

yushey__

Bought GILD puts they have earnings today and I have no idea what they do

ImHungryAsFuck

So far I’m liking these for earnings. Got to see how it pans out by closing. $UPST Puts $FRSH Puts $GILD Puts $WELL Puts

ImHungryAsFuck

So far liking $UPST Puts $FRSH Puts $GILD Puts $WELL Puts

weegee13

!banbet GILD $105 1d

Recent_Register_2952

My wife is a better trader than me. I asked her for 2 stock picks to buy and hold as a way to make her "feel like she is involved" in these decisions. GILD +40% and HNST +150%

midweastern

I really like your portfolio, especially how you're getting some international exposure in some of the few companies worth having a position in. You are a little too heavy in tech imo. I'm not sure I would sell any of your existing positions there, but I wouldn't add any more to them without first investing into another sector. Personally, I would choose an industrial or consumer defensive stock. I'm also not a fan of UNH. I would replace it with a pharma giant like PFE, GSK, or GILD. Alternatively, maybe some sort of real estate like DLR, AMT, or PLD.

ReBoomAutardationism

In general, if the stock is trading below the 50 day moving average you probably want out. The test is whether or not the average is rising or flat. As long as it keeps make new highs, stick around. If it closes below the 50 day a second time without a new high that would be a sign of distribution. If you like a stock like $GILD or $BMY, you can wait a year for it to "come in" and then AVERAGE UP. One the authority of Paul Tudor Jones: Losers Average Losers.

7Billiards

Big pharma. lots of spec around GILD and MRK. The compound from ALT is best in class for lean mass preservation setting it aside from 1st gen weight loss drugs. More DD on r/altimmune or look up Stocktwits user BTECHINV

7Billiards

Not to mention 32% short interest and $600m market cap. Thing is primed on really good MASH data too. I’m not surprised GILD would seek partnership with them.

satanicmajesty

I'm just a degenerate gambler. If this were my portfolio, and if this is not in an IRA, I would sell all those in the red to offset some profits before the end of the year and get into some solid and boring stuff, like CASY, maybe GILD, HD, Costco, maybe some SBUX or some stocks that have dropped greatly and have potential to recover, like SNOW and NIKE. What about some SYK, since you like health stocks? Personally, I just made like 600%+ on RKLB options, have SNOW options and hope we get a good earnings call, and I think I own all the stocks I just mentioned. I'm waiting to buy some NIKE options on a red day to get a good price and maybe sell when it's up 50% or something. Only put like 15% max of what you have in really volatile stuff, put the rest in boring stuff. I have AVGO too, still looks good to me. I still have a bunch of NVDA, but I bought it cheap years ago for like $20. At this point, I wouldn't buy so much until after a dip. After this bull run we've had, I also think maybe we could get a drop, but who knows, right? I would keep some cash money just in case.

bananacakesjoy

if you like ABBV, check out MRK, GILD, BMY, PFE, and SNY, all better fwd p/e, better p/b, etc.

Fit_Ad_5032

What about Gilead (GILD), they have a new HIV prevention which is 98% effective.

NOT_MartinShkreli

Once this rollover to my self managed IRA hits I’m going balls deep in HALO, GMAB, SCYX, GILD … and GME 1/2026 ITM calls. All I need is one more dumb pump over 15 months and I’m rich

NOT_MartinShkreli

I’m a pharmacist, PFE is a terrible bet. Cut that shit If you wanna buy calls go with Gilead or Takeda and long dated If you want something trading low, BIIB is 52 week low and also SCYX is a penny stock I like a lot (have been buying since $10 lol). If you want blue chip go with GILD or TAK. If you had the capital and balls of steel I would say buy puts on Lilly for December at $800 strike

NOT_MartinShkreli

Bahahaha. I’ll probably throw $20k at GameStop LEAPS and just wait for a super volatile week to unload a 4-5 bagger. Then buy some scynexis shares with $5-10k cuz it’s a beat down penny stock with promising antifungal drugs I believe in and think it’ll get bought out. Eventually move to Takeda and GILD as blue chip dividend stocks and diversify out some later when the account is large enough

Fit_Ad_5032

Buy GILD

Lewstz

GILD

they_call_me_him

Those are actually companies with < 10% EPS past 5 years, I was mistaken. But the list for < 10% EPS over the next 5 years is 2x longer, but regardless, these lists mean nothing. Here’s some with the EPS that you mentioned: - SCHL (scholastic) - GILD (Gilead) - NOK (Nokia) - KTOS (kratos defense) - CLX (clorox) - ENR (energizer) Again, this evaluation method of yours is meaningless

No_chance765

Hope someone took my advice on GILD!

BigCyanDinosaur

GILD !!

No_chance765

GILD again

No_chance765

GILD $85c exp 9/20 right before close